Experts map out nuclear medicine's coming decade: theranostics, AI, and novel tracers

Interviews with nuclear medicine leaders highlight the field's rapid expansion toward precision theranostics, AI-augmented image analysis, and next-generation radiotracers for personalized care.

• The piece is a forward-looking news analysis, not an original study or trial — no patient-level data are presented.
• Central themes include the growth of theranostics (e.g., PSMA, DOTATATE) and the integration of artificial intelligence for quantification and workflow.
• Coverage reflects expert opinion from the Diagnostic Imaging editorial board and invited contributors.

RadPigeon summaries are original and for information only. They are not clinical advice.